Randomized double blind trial of amitriptyline versus placebo in treatment of chronic laryngopharyngeal neuropathy

Minyoung Jang; Samuel J. Rubin; Dan Joseph Stein; J. Pieter Noordzij

doi:10.1016/j.amjoto.2017.07.006

Related publications

Article2017

Randomized Double Blind Trial of Amitriptyline versus Placebo in Treatment of Chronic Laryngopharyngeal Neuropathy- Preliminary Results

Minyoung Jang, Samuel J. Rubin, Dan Joseph Stein, J. Pieter Noordzij

Article2010

A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*

Todd W. Rice, Arthur P. Wheeler, Gordon R. Bernard, Jean Louis Vincent, Derek C. Angus, Naoki Aikawa, Ignace Demeyer, Stephen M. Sainati, Nicholas Amlot, Charlie Cao, Masayuki Ii, Hideyasu Matsuda, Kouji Mouri, Jon Cohen

Article2003

An International, Randomized, Double-blind, Placebo-Controlled Phase 3 Trial of Intramuscular Alefacept in Patients With Chronic Plaque Psoriasis

Mark Lebwohl, Enno Christophers, Richard G. Langley, Jean Paul Ortonne, Janet L. Roberts, Christopher Em Griffiths

Article2012

Randomized, Double-Blind, Placebo-Controlled Trial of Monthly versus Bimonthly Dihydroartemisinin-Piperaquine Chemoprevention in Adults at High Risk of Malaria

Khin Maung Lwin, Aung Pyae Phyo, Joel Tärning, Warunee Hanpithakpong, Elizabeth A. Ashley, Sue J. Lee, Phaikyeong Cheah, Pratap Singhasivanon, Sir Nicholas White, Niklas Lindegårdh, François Nosten

Antimicrobial Agents and Chemotherapy

Article2008

Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial

Jacqueline E. Muller, Ignatius Wentzel, Liezl Koen, Dana Niehaus, Soraya Seedat, Dan Joseph Stein